Sunday, July 29, 2012
Diabetes drug improves survival from life-threatening infectious disease
Scientists have identified a diabetes drug which halves the mortality rate of a deadly infectious disease found throughout Southeast Asia and Northern Australia. Melioidosis, caused by a soil dwelling bacterium (Burkholderia pseudomallei) that is present in certain regions of the world, results in severe infections include bloodstream infections and pneumonia. Death results in up to 40% of affected individuals despite antibiotic treatment. New research by a multinational team from the United Kingdom, Thailand, Singapore and The Netherlands, however, has found that people taking the diabetes drug glibenclamide (called glyburide in the US) have half the mortality of other patients with melioidosis.
posted by SCIENCE NEWS at 2:01 AM